Viewing Study NCT07102394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT07102394
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-12
First Post: 2025-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Sponsor: Johns Hopkins University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NF1 View
None Neurofibromatosis View
None Cutaneous Neurofibroma View
None Neurofibroma View
None Von Recklinghausen Disease View
None Neurofibromas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NF1 View
None neurofibromatosis View
None cutaneous neurofibroma View
None IMLYGIC View
None T-VEC View
None Neurofibromatosis type 1 View
None neurofibroma View